Statement of the Problem: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become the gold standard for the treatment of type 2 diabetes mellitus (T2DM). However, the therapeutic ... benefits of GLP-1 are…
lowers postprandial plasma glucose by enhancing insulin secretion, insulin sensitivity or through GLP-1 in the two study groups. GLP-1 is known to increase stimulation of insulin secretion ... secretion was lower and…
glucagon-like peptide-1 receptor agonist (GLP-1RA) Semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous ... oral formulation. While GLP-1RAs…
glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous ... oral formulation. While GLP-1RAs…
Administration of cholecystokinin (CCK) or the glucagon-like peptide 1 (GLP-1) receptor agonist Exendin-4 (Ex-4) reduces food intake. Findings in the literature suggest CCK reduces intake primarily ... satiety signal…
Administration of cholecystokinin (CCK) or the glucagon-like peptide 1 (GLP-1) receptor agonist Exendin-4 (Ex-4) reduces food intake. Findings in the literature suggest CCK reduces intake primarily ... satiety signal…
glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous ... oral formulation. While GLP-1RAs…
develop a topical nanoemulgel of a BCS class II drug, Glimepiride (GLP) in both and inclusion complexed form. In our previous studies, we prepared binary and ternary inclusion complexes ... GLP by physical trituration…
Glucagon like peptide-1 (GLP-1) plays a vital role in glucose homeostasis and sustaining β-cell function. Currently there are two major methods to enhance endogenous GLP-1 activity ... dependent manner. A single…
reduce the risk of late-stage complications. The incretin hormone glucagon-like peptide 1 (GLP-1) is a potent simulator of endogenous insulin release. GLP-1 possesses several physiological properties ... stomach…
aspect of prevention mechanism of diabetes mellitus by natural flavonoids. GLUT4, AMPK, and GLP-1 are key molecules for prevention of hyperglycemia and maintain glucose homeostasis. We found epigallocatechin ... vivo…
minutes post ingestion and analyzed for glucose, insulin, glucagon-like peptide-1 (GLP-1), glucagon, ATP, and brainderived neurotrophic factor (BDNF). Results: Significant reductions in the area under the curve…
Glucagon like peptide-1 (GLP-1) plays a vital role in glucose homeostasis and sustaining β-cell function. Currently there are two major methods to enhance endogenous GLP-1 activity ... dependent manner. A single…
week 12 for FBS, insulin, lipid profile, hs-CRP, IL-6, PYY and GLP-1. The mean changes of weight, BMI, FBS, insulin, HOMA-IR and GLP-1 between ... Treatment with synbiotic may improve the status of BMI, FBS, Insulin…
have led to the discovery of numerous antidiabetic peptides. Nevertheless, these drugs like insulin, GLP-1 and its analogs are currently administrated parenterally, a route which is not well accepted ... patients, and…
control group (n=22). Blood glucose levels, IRI, GLP-1, GIP and glucagon during the OGTT (with 75 g glucose) at 0, 30, 60 and 120 min. were measured ... groups: 4 individuals (17.4%) even showed postprandial…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.